期刊
AIDS AND BEHAVIOR
卷 26, 期 1, 页码 57-68出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10461-021-03332-7
关键词
COVID-19; Coronavirus; Syringe services programs; Syringe exchange
资金
- Centers for Disease Control and Prevention [5 NU65 PS923685-01]
- Veterans Affairs Puget Sound Research and Development Service
- National Institute of Diabetes and Digestive and Kidney Diseases [5 T32 DK007742-22]
SSPs faced challenges such as reduced service reach, suspended testing, high risk among PWUD, and negative impacts of isolation during the COVID-19 pandemic, but also identified opportunities for improving services, providing valuable insights for the future.
Syringe services programs (SSPs) are essential to preventing injection drug use-related infections and overdose death among people who use drugs (PWUD). The novel coronavirus (COVID-19) pandemic initially impeded SSPs' operations. To effectively support these programs, information is needed regarding SSPs' experiences adapting their services and the challenges posed by COVID-19. We conducted qualitative interviews with leadership and staff from a sample of 31 U.S. SSPs. Respondents discussed urgent concerns including reduced reach of services, suspended HIV/hepatitis C testing, high COVID-19 risk among PWUD, and negative impacts of isolation on overdose and mental health. They also noted opportunities to improve future services for PWUD, including shifting to evidence-based distribution practices and maintaining regulatory changes that increased access to opioid use disorder medications post-pandemic. Findings can inform efforts to support SSPs in restoring and expanding services, and provide insight into SSPs' role in engaging PWUD during the COVID-19 response and future emergencies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据